Medtronic has recalled more than 204,000 devices used to assist hospital and other patients with end-stage heart failure due to the potential for power source interruptions, the Food and Drug Administration reported Friday. The HeartWare Ventricular Assist Device is used as a bridge to cardiac transplantation in patients who are at risk of death from end-stage left ventricular heart failure. Health care professionals and consumers may report adverse reactions and quality problems with the devices to the FDA’s MedWatch program. For more information, see the recent Medtronic letter to health care providers.

Related News Articles

Headline
HHS and the Department of Defense’s Defense Threat Reduction Agency will provide funding to VenatoRx Pharmaceuticals to develop a novel antibiotic to treat…
Headline
HHS is soliciting input and will meet with vendors Aug. 7-8 to spur innovation in developing new technologies and products to save lives and improve health…
Headline
The Centers for Disease Control and Prevention is working with the U.S. Embassy in the Democratic Republic of the Congo to preposition staff in Goma to rapidly…
Headline
The World Health Organization today declared the Ebola virus disease outbreak in the Democratic Republic of the Congo a public health emergency of…
Headline
The Centers for Medicare…
Headline
CMS anticipates releasing later this summer the feedback it received on potential methodology changes to the overall hospital quality star ratings, the agency…